Abstract:Background: Non-healing ulcers are a major health problem worldwide and have great impact at personal, professional and social levels, with high cost in terms of human and material resources. Recalcitrant non-healing ulcers are inevitable and detrimental to the lower limb and are a major cause of non-traumatic lower limb amputations. Application of autologous Platelet Rich Plasma (PRP) has been a major breakthrough for the treatment of non-healing and diabetic foot ulcers, as it is an easy and cost-effective method, and provides the necessary growth factors that enhance tissue healing. PRP is a conglomeration of thrombocytes, cytokines and various growth factors which are secreted by α-granules of platelets that augment the rate of natural healing process with decrease in time. The purpose of this case series was to evaluate the safety and efficacy of autologous platelet rich plasma for the treatment of chronic non-healing ulcers on the lower extremity. Methods: Autologous PRP was prepared from whole blood utilizing a rapid, intraoperative point-of-care system that works on the principle of density gradient centrifugation. Twenty Four (24) patients with non-healing ulcers of different etiologies, who met the inclusion criteria, were treated with single dose of subcutaneous PRP injections along with topical application of PRP gel under compassionate use. Results: The mean age of the treated patients was 62.5 ± 13.53 years and they were followed-up for a period of 24 weeks. All the patients showed signs of wound healing with reduction in wound size, and the mean time duration to ulcer healing was 8.2 weeks. Also, an average five fold increase in the platelet concentrate was observed in the final PRP product obtained using the rapid point-of-care device, and the average platelet dose administered to the patients was 70.10 × 108. Conclusion: This case series has demonstrated the potential safety and efficacy of autologous platelet rich plasma for the treatment of chronic non-healing ulcers. Trial registration: NCT03026855 , Registered 4 January 2017 'Retrospectively'.

The Additive Effect of Platelet-Rich Plasma in the Treatment of Actively Bleeding Peptic Ulcer

Systematic Review with Network Meta-Analysis: Dual Therapy for High-Risk Bleeding Peptic Ulcers

Efficacy of Topical Recombinant Human Platelet-Derived Growth Factor for Treatment of Diabetic Lower-Extremity Ulcers: Systematic Review and Meta-Analysis

Efficacy of Local Autologous Platelet-Rich Plasma in the Treatment of Chronic Ulcer

Comparison of the efficacy of two combined therapies for peptic ulcer bleeding: adrenaline injection plus haemoclipping versus adrenaline injection followed by bipolar electrocoagulation

Effectiveness of Platelet-Rich Plasma and Hyaluronic Acid for the Treatment and Care of Pressure Ulcers

Turn over the new leaf of the treatment in peptic ulcer bleeding: a review of the literature

Efficacy and Safety of Platelet-Rich Plasma for Pressure Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Endoscopic hemostasis for peptic ulcer bleeding: systematic review and meta-analyses of randomized controlled trials

EFFICACY OF INTRAVENOUS ADMINISTRATION OF OMEPRAZOLEIN THE TREATMENT OF UPPER GASTROINTESTINAL HEMORRHAGE CAUSED BY PEPTIC ULCER AND ACUTE GASTRIC MUCOSAL LESION

Randomized Comparison of a Novel Hemostatic Clip (resolution Clip™) to Combined Epinephrine Injection and Heater Probe (HP) Thermocoagulation in Endoscopic Control of Peptic Ulcer Bleeding (PUB)

Efficacy and safety of platelet‐rich plasma in the treatment of venous ulcers: A systematic review and meta‐analysis of randomized controlled trials

Efficacy of a novel self-assembling peptide hemostatic gel as rescue therapy for refractory acute gastrointestinal bleeding

Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding.

Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers.

Adding a sclerosant to endoscopic epinephrine injection in actively bleeding ulcers: a randomized trial

Recent advances in the management of peptic ulcer bleeding

Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series

Factors influencing re-bleeding after trans-arterial embolization for endoscopically unmanageable peptic ulcer bleeding

Hemostatic spray powder TC-325 in the primary endoscopic treatment of peptic ulcer-related bleeding: multicenter international registry

Meta-Analysis of Platelet-Rich Plasma in the Treatment of Lower Extremity Venous Ulcer